1. Elevated plasma concentrations of brain natriuretic peptide are fou
nd in conditions associated with impaired left ventricular diastolic f
unction, The purpose of this study was to determine whether this pepti
de actually plays a physiological role in improving myocardial perform
ance in diastole. 2. Nine normal subjects received infusions of brain
natriuretic peptide or placebo in a randomized, double-blind, crossove
r study, Brain natriuretic peptide infusion produced a significant red
uction in isovolumic relaxation time (means and 95% confidence interva
l for difference -10.8 ms, -14.5 to -7.0 ms) (P<0.01) and significantl
y increased both the peak E/A velocity (0.54, 0.14-0.94) (P<0.05) and
the E/A time velocity integral (1.09, 0.20-1.98) (P<0.05). 3. These re
sponses were evident at concentrations of brain natriuretic peptide th
at produced no associated effects on blood pressure, heart rate or str
oke distance. 4. Brain natriuretic peptide infusion in normal subjects
significantly reduces isovolumic relaxation time and improves transmi
tral Doppler flow profiles, suggesting that this peptide may be import
ant in the control of left ventricular diastolic relaxation in man.